# Lexicon Pharmaceuticals, Inc.: Form 8-K, filed May 10, 2024

- Company: [Lexicon Pharmaceuticals, Inc.](/companies/lxrx.md) (CIK 1062822)
- Form: 8-K
- Filed: 2024-05-10
- Accepted by EDGAR: May 10, 2024, 16:15 ET
- Period: 2024-05-10
- Accession: 0001062822-24-000029
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1062822/000106282224000029/lxrx-20240510.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1062822/000106282224000029/

## Items reported

- Item 3.02: Unregistered sale of equity
- Item 5.03: Amendment to articles or bylaws
- Item 5.07: Shareholder vote results
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1062822/000106282224000029/lxrx-20240510.htm

Filed May 10, 2024.
Source: SEC EDGAR, the filing index for accession 0001062822-24-000029. Last ingested by Listed: Nov 9, 2026, 17:52 ET. No prices; not investment advice.